The Food and Drug Administration (FDA) has amended emergency use authorization (EUA) for COVID-19 vaccines to allow booster doses for the Moderna and Johnson & Johnson vaccines. Specifically, the EUA allows for a single-dose booster in the following circumstances: Ages 65 and older Ages 18-64 at high risk of severe COVID-19 Ages 18-64 with frequent institutional or occupational exposure to SARS-CoV-2 The use of a...
This content is restricted to members.
